Clinical Trial Update: Randomized Trial of Adjuvant Chemotherapy With Cisplatin Followed by UFT in Serosa-positive Gastric Cancer (JCOG9206-2) [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial assessed adjuvant chemotherapy with cisplatin followed by UFT in serosa-positive gastric cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• UFT (tegafur-uracil)

Snippet

Sponsor: Japan Clinical Oncology Group | Conditions: Gastric Neoplasm | Phase 3 | Status: COMPLETED